ppGpp formation in Escherichia coli treated with rifampicin.
D000604:Amino Acyl-tRNA Synthetases / Q000037:antagonists & inhibitors; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D003864:Depression, Chemical; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D005827:Genetics, Microbial; D006150:Guanine Nucleotides / Q000096:biosynthesis*; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008433:Mathematics; D008660:Metabolism / Q000187:drug effects; D009154:Mutation; D010710:Phosphates / Q000378:metabolism; D010759:Phosphorus Isotopes; D012313:RNA / Q000096:biosynthesis; D012343:RNA, Transfer; D012293:Rifampin / Q000494:pharmacology*; D013696:Temperature; D046249:Transfer RNA Aminoacylation; D014633:Valine / Q000494:pharmacology
D001426:Bacterial Proteins; D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D010710:Phosphates; D010759:Phosphorus Isotopes; D012313:RNA; D012343:RNA, Transfer; D000604:Amino Acyl-tRNA Synthetases; D007930:Leucine; D014633:Valine; D012293:Rifampin